Viewing Study NCT04783766


Ignite Creation Date: 2025-12-24 @ 4:23 PM
Ignite Modification Date: 2026-01-05 @ 3:05 AM
Study NCT ID: NCT04783766
Status: COMPLETED
Last Update Posted: 2025-01-24
First Post: 2021-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Pharmacokinetics Study of CK-3773274
Sponsor: Corxel Pharmaceuticals
Organization:

Study Overview

Official Title: A Phase 1, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of CK-3773274 in Healthy Chinese Subjects
Status: COMPLETED
Status Verified Date: 2025-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purposes of this study are to:

1. Learn about the safety of CK-3773274 after a single dose and multiple doses in Chinese healthy adult subjects.
2. Learn how healthy subjects tolerate CK-3773274 after a single dose and multiple doses.
3. Find out how much CK-3773274 is in the blood after a single dose and multiple doses.
4. Determine the effect of doses of CK-3773274 on the pumping function of the heart.
5. Evaluate the effect CYP2D6 genetic polymorphisms on how the body metabolizes CK-3773274.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
CTR20210291 OTHER China CDE clinical trial registration View